Form 8-K - Current report:
SEC Accession No. 0001493152-25-003091
Filing Date
2025-01-21
Accepted
2025-01-21 17:10:33
Documents
15
Period of Report
2025-01-17
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 52211
2 ex3-1.htm EX-3.1 16755
  Complete submission text file 0001493152-25-003091.txt   251561

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE envb-20250117.xsd EX-101.SCH 3012
4 XBRL LABEL FILE envb-20250117_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE envb-20250117_pre.xml EX-101.PRE 22357
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3944
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38286 | Film No.: 25543260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)